The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies

References

• [cited 2018 Feb 24]. Available from: https://www.goodreads.com/author/show/194459.Maimonides
   Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012 Dec 15;380(9859):2163–2196. PubMed PMID: 23245607.
   PubMed Web of Science ®Google Scholar
• Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012 Dec 15;380(9859):2224–2260. PubMed PMID: 23245609; PubMed Central PMCID: PMCPMC4156511.
   PubMed Web of Science ®Google Scholar
• Papi A, Brightling C, Pedersen SE, et al. Asthma. Lancet. 2017 Dec 19 PubMed PMID: 29273246. DOI:10.1016/S0140-6736(17)33311-1.
   Google Scholar
• Ferreira DS, Carvalho-Pinto RM, Gregorio MG, et al. Airway pathology in severe asthma is related to airflow obstruction but not symptom control. Allergy. 2018 Mar;73(3):635–643. PubMed PMID: 28960335.
   PubMed Web of Science ®Google Scholar
• Maio S, Baldacci S, Bresciani M, et al. RItA: the Italian severe/uncontrolled asthma registry. Allergy. 2018 Mar;73(3):683–695. PubMed PMID: 29072882.
   PubMed Web of Science ®Google Scholar
• Samitas K, Carter A, Kariyawasam HH, et al. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2017 Dec 1 PubMed PMID: 29197105. DOI:10.1111/all.13373.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Nakatani E, Fukutomi Y, et al. Identification of patterns of factors preceding severe or life-threatening asthma exacerbations in a nationwide study. Allergy. 2017 Dec 1 PubMed PMID: 29197099. DOI:10.1111/all.13374.
   Web of Science ®Google Scholar
• Akbarshahi H, Menzel M, Ramu S, et al. House dust mite impairs antiviral response in asthma exacerbation models through its effects on TLR3. Allergy. 2018 Jan 10 PubMed PMID: 29319193. DOI:10.1111/all.13378.
   PubMed Web of Science ®Google Scholar
• Lockey RF. Asthma phenotypes: an approach to the diagnosis and treatment of asthma. J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):682–685. PubMed PMID: 25439357.
   PubMed Web of Science ®Google Scholar
• Schwarze J, Openshaw P, Jha A, et al. Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force. Allergy. 2017 Nov 6. PubMed PMID: 29105786. DOI:10.1111/all.13333
   Web of Science ®Google Scholar
• 2018. GINA Report. [cited 2018 Apr 05]. Available from: http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/
   Google Scholar
• Fuchs O, Bahmer T, Rabe KF, et al. Asthma transition from childhood into adulthood. Lancet Respir Med. 2017 Mar;5(3):224–234. PubMed PMID: 27666650.
   PubMed Web of Science ®Google Scholar
• Agache I, Akdis C, Jutel M, et al. Untangling asthma phenotypes and endotypes. Allergy. 2012 Jul;67(7):835–846. PubMed PMID: 22594878.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European academy of allergy and clinical immunology and the American academy of allergy, asthma & immunology. J Allergy Clin Immunol. 2013 Jun;131(6):1479–1490. PubMed PMID: 23587334; PubMed Central PMCID: PMCPMC4161279.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Ballas ZK. Precision medicine and precision health: building blocks to foster a revolutionary health care model. J Allergy Clin Immunol. 2016 May;137(5):1359–1361. PubMed PMID: 27155031.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Akdis M, Akdis CA. Precision medicine in allergic disorders. Curr Treat Opt Allergy. 2017;4(3):283–285.
   Google Scholar
• Agache I, Sugita K, Morita H, et al. The complex type 2 endotype in allergy and asthma: from laboratory to bedside. Curr Allergy Asthma Rep. 2015 Jun;15(6):29. PubMed PMID: 26141574.
   PubMed Web of Science ®Google Scholar
• Berry A, Busse WW. Biomarkers in asthmatic patients: has their time come to direct treatment? J Allergy Clin Immunol. 2016 May;137(5):1317–1324. PubMed PMID: 27155028.
   PubMed Web of Science ®Google Scholar
• Svenningsen S, Nair P. Asthma endotypes and an overview of targeted therapy for asthma. Front Med (Lausanne). 2017;4:158. PubMed PMID: 29018800; PubMed Central PMCID: PMCPMC5622943.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010 Feb 15;181(4):315–323. PubMed PMID: 19892860; PubMed Central PMCID: PMCPMC2822971.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012 May 4;18(5):716–725. PubMed PMID: 22561835.
   PubMed Web of Science ®Google Scholar
• Beretta C, Rifflart C, Evrard G, et al. Assessment of eosinophilic airway inflammation as a contribution to the diagnosis of occupational asthma. Allergy. 2018 Jan;73(1):206–213. PubMed PMID: 28771844.
   PubMed Web of Science ®Google Scholar
• Dunn RM, Busse PJ, Wechsler ME. Asthma in the elderly and late-onset adult asthma. Allergy. 2018 Feb;73(2):284–294. PubMed PMID: 28722758.
   PubMed Web of Science ®Google Scholar
• Amat F, Labbe A. Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab? Expert Rev Respir Med. 2018 Jun;12(6):475–482. PubMed PMID: 29741411.
   PubMed Web of Science ®Google Scholar
• Fux M, von Garnier C. Sputum basophils and asthma diagnosis: dawn of a new era? Allergy. 2017 Oct;72(10):1437–1439. PubMed PMID: 28561329.
   PubMed Web of Science ®Google Scholar
• Konig K, Klemens C, Eder K, et al. Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis. Allergy Asthma Clin Immunol. 2015;11(1):26. PubMed PMID: 26401140; PubMed Central PMCID: PMCPMC4580351.
   PubMedGoogle Scholar
• Chen F, Hong H, Sun Y, et al. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study. Ann Allergy Asthma Immunol. 2017 Oct;119(4):310–316 e2. PubMed PMID: 28870448.
   PubMed Web of Science ®Google Scholar
• Agache I, Strasser DS, Klenk A, et al. Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics. Allergy. 2016 Aug;71(8):1192–1202. PubMed PMID: 27060452.
   PubMed Web of Science ®Google Scholar
• Hesse L, Van Ieperen N, Habraken C, et al. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model. Allergy. 2018 Jan 10 PubMed PMID: 29318623. DOI:10.1111/all.13382.
   PubMedGoogle Scholar
• Kortekaas Krohn I, Shikhagaie MM, Golebski K, et al. Emerging roles of innate lymphoid cells in inflammatory diseases: clinical implications. Allergy. 2017 Oct 25 PubMed PMID: 29069535. DOI:10.1111/all.13340.
   Web of Science ®Google Scholar
• Akdis CA, Akdis M. Advances in allergen immunotherapy: aiming for complete tolerance to allergens. Sci Transl Med. 2015 Mar 25;7(280):280ps6. PubMed PMID: 25810310.
   PubMed Web of Science ®Google Scholar
• Akdis M, Aab A, Altunbulakli C, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016 Oct;138(4):984–1010. PubMed PMID: 27577879.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schunemann HJ, Samolinski B, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012 Nov;130(5):1049–1062. PubMed PMID: 23040884.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Hellings PW, Agache I, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47. PubMed PMID: 28050247; PubMed Central PMCID: PMCPMC5203711.
   PubMed Web of Science ®Google Scholar
• Couto M, Kurowski M, Moreira A, et al. Mechanisms of exercise-induced bronchoconstriction in athletes: current perspectives and future challenges. Allergy. 2018 Jan;73(1):8–16. PubMed PMID: 28599081.
   PubMed Web of Science ®Google Scholar
• Crossman-Barnes CJ, Peel A, Fong-Soe-Khioe R, et al. Economic evidence for nonpharmacological asthma management interventions: A systematic review. Allergy. 2017 Nov 6. PubMed PMID: 29105788. DOI:10.1111/all.13337
   PubMed Web of Science ®Google Scholar
• Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology. 2004 Jul;112(3):352–363. PubMed PMID: 15196202; PubMed Central PMCID: PMCPMC1782506.
   PubMed Web of Science ®Google Scholar
• Dhami S, Kakourou A, Asamoah F, et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017 Dec;72(12):1825–1848. PubMed PMID: 28543086.
   PubMed Web of Science ®Google Scholar
• Platts-Mills TAE, Schuyler AJ, Erwin EA, et al. IgE in the diagnosis and treatment of allergic disease. J Allergy Clin Immunol. 2016 Jun;137(6):1662–1670. PubMed PMID: 27264001; PubMed Central PMCID: PMCPMC5406226.
   PubMed Web of Science ®Google Scholar
• Oettgen HC. Fifty years later: emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases. J Allergy Clin Immunol. 2016 Jun;137(6):1631–1645. PubMed PMID: 27263999; PubMed Central PMCID: PMCPMC4898788.
   PubMed Web of Science ®Google Scholar
• Ferstl R, Frei R, Barcik W, et al. Histamine receptor 2 modifies iNKT cell activity within the inflamed lung. Allergy. 2017 Dec;72(12):1925–1935. PubMed PMID: 28618071.
   PubMed Web of Science ®Google Scholar
• Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S73–80. PubMed PMID: 20176269; PubMed Central PMCID: PMCPMC2847274.
   PubMed Web of Science ®Google Scholar
• Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998 Dec 18;282(5397):2258–2261. PubMed PMID: 9856949.
   PubMed Web of Science ®Google Scholar
• Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004 Jun 7;199(11):1567–1575. PubMed PMID: 15173208; PubMed Central PMCID: PMCPMC2211782.
   PubMed Web of Science ®Google Scholar
• Sharma N, Akkoyunlu M, Rabin RL. Macrophages-common culprit in obesity and asthma. Allergy. 2017 Nov 27. PubMed PMID: 29178573. DOI:10.1111/all.13369
   PubMed Web of Science ®Google Scholar
• Morita H, Moro K, Koyasu S. Innate lymphoid cells in allergic and nonallergic inflammation. J Allergy Clin Immunol. 2016 Nov;138(5):1253–1264. PubMed PMID: 27817797.
   PubMed Web of Science ®Google Scholar
• Morita H, Arae K, Unno H, et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity. 2015 Jul 21;43(1):175–186. PubMed PMID: 26200013; PubMed Central PMCID: PMCPMC4533925.
   PubMed Web of Science ®Google Scholar
• Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015 Mar;135(3):626–635. PubMed PMID: 25528359.
   PubMed Web of Science ®Google Scholar
• Maggi L, Montaini G, Mazzoni A, et al. Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production. J Allergy Clin Immunol. 2017 Mar;139(3):964–976 e4. PubMed PMID: 27576126.
   PubMed Web of Science ®Google Scholar
• Noval Rivas M, Burton OT, Oettgen HC, et al. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J Allergy Clin Immunol. 2016 Sep;138(3):801–811 e9. PubMed PMID: 27177780; PubMed Central PMCID: PMCPMC5014699.
   PubMed Web of Science ®Google Scholar
• Salimi M, Barlow JL, Saunders SP, et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med. 2013 Dec 16;210(13):2939–2950. PubMed PMID: 24323357; PubMed Central PMCID: PMCPMC3865470.
   PubMed Web of Science ®Google Scholar
• Sugita K, Steer CA, Martinez-Gonzalez I, et al. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018 Jan;141(1):300–310 e11. PubMed PMID: 28392332.
   PubMed Web of Science ®Google Scholar
• Komlosi ZI, Kovacs N, van de Veen W, et al. Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol. PubMed PMID: 28939410 Sep 20 2017. DOI:10.1016/j.jaci.2017.07.046
   PubMed Web of Science ®Google Scholar
• Lombardi V, Beuraud C, Neukirch C, et al. Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjects. J Allergy Clin Immunol. 2016 Jul;138(1):305–308. PubMed PMID: 26949057.
   PubMed Web of Science ®Google Scholar
• Kucuksezer UC, Palomares O, Ruckert B, et al. Triggering of specific toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol. 2013 Mar;131(3):875–885. PubMed PMID: 23265862.
   PubMed Web of Science ®Google Scholar
• Gueguen C, Bouley J, Moussu H, et al. Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy. J Allergy Clin Immunol. 2016 Feb;137(2):545–558. PubMed PMID: 26522402.
   PubMed Web of Science ®Google Scholar
• Sirvent S, Soria I, Cirauqui C, et al. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. J Allergy Clin Immunol. 2016 Aug;138(2):558–567 e11. PubMed PMID: 27177779.
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012 May 4;18(5):693–704. PubMed PMID: 22561833; PubMed Central PMCID: PMCPMC3597223.
   PubMed Web of Science ®Google Scholar
• Palomares O, Akdis M, Martin-Fontecha M, et al. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017 Jul;278(1):219–236. PubMed PMID: 28658547.
   PubMed Web of Science ®Google Scholar
• van de Veen W, Stanic B, Of W, et al. Role of regulatory B cells in immune tolerance to allergens and beyond. J Allergy Clin Immunol. 2016 Sep;138(3):654–665. PubMed PMID: 27596706.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Kucuksezer UC, Akdis M, et al. Specific immunotherapy and turning off the T cell: how does it work? Ann Allergy Asthma Immunol. 2011 Nov;107(5):381–392. PubMed PMID: 22018608.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Kucuksezer UC, Akdis M, et al. Mechanisms of aeroallergen immunotherapy: subcutaneous immunotherapy and sublingual immunotherapy. Immunol Allergy Clin North Am. 2016 Feb;36(1):71–86. PubMed PMID: 26617228.
   PubMed Web of Science ®Google Scholar
• Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy. 2017 Nov;72(11):1597–1631. PubMed PMID: 28493631.
   PubMed Web of Science ®Google Scholar
• Dhami S, Zaman H, Varga EM, et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy. 2017 Mar;72(3):342–365. PubMed PMID: 28120424.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Yazi D, Gocmen I, et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol. 2007 Sep;18(6):508–515. PubMed PMID: 17680909.
   PubMed Web of Science ®Google Scholar
• Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015 Sep;136(3):556–568. PubMed PMID: 26162571.
   PubMed Web of Science ®Google Scholar
• Berings M, Karaaslan C, Altunbulakli C, et al. Advances and highlights in allergen immunotherapy: on the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 Nov;140(5):1250–1267. PubMed PMID: 28941667.
   PubMed Web of Science ®Google Scholar
• Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2017 Sep 23 PubMed PMID: 28940458. DOI:10.1111/all.13317.
   Google Scholar
• Satitsuksanoa P, Globinska A, Jansen K, et al. Modified allergens for immunotherapy. Curr Allergy Asthma Rep. 2018 Feb 16;18(2):9. 10.1007/s11882-018-0766-x. PubMed PMID: 29450658.
   PubMed Web of Science ®Google Scholar
• Agache I, Strasser DS, Pierlot GM, et al. Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma. J Allergy Clin Immunol. 2018 Jan;141(1):442–445. PubMed PMID: 28987809.
   PubMed Web of Science ®Google Scholar
• Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax. 1999 Mar;54(3):268–272. PubMed PMID: 10325905; PubMed Central PMCID: PMCPMC1745435.
   PubMed Web of Science ®Google Scholar
• Berry M, Morgan A, Shaw DE, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007 Dec;62(12):1043–1049. PubMed PMID: 17356056; PubMed Central PMCID: PMCPMC2094295.
   PubMed Web of Science ®Google Scholar
• Kim H, Ellis AK, Fischer D, et al. Asthma biomarkers in the age of biologics. Allergy Asthma Clin Immunol. 2017;13:48. PubMed PMID: 29176991; PubMed Central PMCID: PMCPMC5691861.
   PubMed Web of Science ®Google Scholar
• Castro M, Zangrilli J, Wechsler ME, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015 May;3(5):355–366. PubMed PMID: 25736990.
   PubMed Web of Science ®Google Scholar
• Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014 Sep 25;371(13):1198–1207. PubMed PMID: 25199059.
   PubMed Web of Science ®Google Scholar
• Farne HA, Wilson A, Powell C, et al. Anti-IL5 therapies for asthma. Cochrane Database Syst Rev. 2017 Sep 21;9:CD010834. PubMed PMID: 28933516.
   PubMed Web of Science ®Google Scholar
• Ozdemir C. Monoclonal antibodies in allergy; updated applications and promising trials. Recent Pat Inflamm Allergy Drug Discov. 2015;9(1): 54–65. PubMed PMID: 25706526.
   PubMedGoogle Scholar
• Sehmi R, Lim HF, Mukherjee M, et al. Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma. J Allergy Clin Immunol. 2018 Jan 27 PubMed PMID: 29382593. DOI:10.1016/j.jaci.2018.01.008.
   Web of Science ®Google Scholar
• Pelaia C, Vatrella A, Gallelli L, et al. Dupilumab for the treatment of asthma. Expert Opin Biol Ther. 2017 Dec;17(12):1565–1572. PubMed PMID: 28990423.
   PubMed Web of Science ®Google Scholar
• Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013 Jun 27;368(26):2455–2466. PubMed PMID: 23688323.
   PubMed Web of Science ®Google Scholar
• Bagnasco D, Ferrando M, Varricchi G, et al. A critical evaluation of anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma. Int Arch Allergy Immunol. 2016;170(2):122–131. PubMed PMID: 27637004.
   PubMed Web of Science ®Google Scholar
• Scheerens H, Arron JR, Zheng Y, et al. The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin Exp Allergy. 2014 Jan;44(1):38–46. PubMed PMID: 24131304; PubMed Central PMCID: PMCPMC4204278.
   PubMed Web of Science ®Google Scholar
• Izuhara K, Nunomura S, Nanri Y, et al. Periostin in inflammation and allergy. Cell Mol Life Sci. 2017 Dec;74(23):4293–4303. 10.1007/s00018-017-2648-0. PubMed PMID: 28887633.
   PubMed Web of Science ®Google Scholar
• Lotvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011 Feb;127(2):355–360. PubMed PMID: 21281866.
   PubMed Web of Science ®Google Scholar